LeishNano is a spin-off startup from the Federal University of Rio de Janeiro – UFRJ, Brazil. The company is focused on drug and vaccine nanoformulation development aiming at technology transfer. Available LeishNano technologies include:
i) Drug-loaded biodegradable nanoparticle/microparticle platform for single-dose treatment of chronic diseases. A prototype formulation is now ready for leishmaniasis treatment;
ii) Mucopenetrating vaccine formulations for intranasal and oral delivery. A prototype vaccine formulation is now ready for intranasal vaccination against Canine Visceral Leishmaniasis, which is effective from birth.
Company Details
- Founded
- 2016
- Address
- Leblon, Rio De Janeiro,rj,brazil
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Rio de Janeiro, RJ
Leishnano Questions
Leishnano's LinkedIn profile is https://br.linkedin.com/company/leishnano
Leishnano's industry is
Biotechnology Research
Leishnano's top competitors are
Remedy Product Studio,
Silva,
Insead Alumni Association Brazil - Iaab.
Leishnano's categories are Biotechnology Research
Leishnano's founding year is 2016
